These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 17737482)

  • 21. Possible involvement of cGMP in the control of tyrosine aminotransferase degradation in rat hepatocytes.
    Strinden ST; Stellwagen RH
    J Cell Physiol; 1983 Oct; 117(1):69-75. PubMed ID: 6137488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of mold contaminants on solid media by the use of actidione.
    PHILLIPS GB; HANEL E
    J Bacteriol; 1950 Jul; 60(1):104-5. PubMed ID: 15436468
    [No Abstract]   [Full Text] [Related]  

  • 23. Suppression by actidione of development of rat liver L-tyrosine: 2-oxoglutarate aminotransferase activity.
    Benson PF; Young PM
    Science; 1968 Jan; 159(3810):97. PubMed ID: 4383510
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of chicken liver mitochondrial alanine:2-oxoglutarate aminotransferase and its response to starvation.
    Fujiwara S; Sakuraba H; Noguchi T
    Arch Biochem Biophys; 1994 May; 310(2):497-503. PubMed ID: 8179338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superinduction of tyrosine aminotransferase in RLC-cells.
    Kröger H; Donner I; Voss H; Plötze G
    Biomedicine; 1979 Jul; 31(4):89-92. PubMed ID: 39644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Separation of L-tyrosine: 2-oxoglutarate aminotransferase from rat liver and changes in enzyme fractions under the influence of hydrocortisone].
    Levin FB
    Dokl Akad Nauk SSSR; 1966 Jun; 168(6):1422-4. PubMed ID: 4385412
    [No Abstract]   [Full Text] [Related]  

  • 27. Suppression by actidione of development of rat liver L-tyrosine : 2-oxoglutarate aminotransferase activity.
    Benson PF; Young PM
    Science; 1968 Jan; 159(3810):97. PubMed ID: 17737482
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.